Clinical Trial Update: Retapamulin for Reducing MRSA Nasal Carriage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether retapamulin reduces nasal carriage of methicillin-resistant Staphylococcus aureus; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus

Drugs mentioned

• Retapamulin (retapamulin)

Snippet

Sponsor: University of California, Irvine | Conditions: Methicillin-Resistant Staphylococcus Aureus | Phase 4 | Status: COMPLETED | Results posted: 2018-04-02